AMLX

AmylyxD

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

At close

2026-06-02

View Chart

Peers tracked

U.S. public peers

Grade Position

Below peers

vs peer average

AMLX vs peer average

30/100

AMLX vs. peer average (D vs. C)

Grade spread

A 3 · C 2 · D 2 · F 1

Graded peers loaded

Coverage

10 graded

100% of tracked

Peer overview

AMPH is the first available peer comparator.

Amphastar is not a direct operating peer, but as a profitable specialty pharma it highlights that AMLX still carries materially higher binary development risk and weaker earnings support than more commercialized healthcare names.

✓Peer source comes from the stored AI memo or peer model

✓Grades and factor rows use RankAlpha API data when available

✓Missing peer scores remain blank instead of being estimated

✓Side-by-side comparison keeps the data contract visible

Top peerAMPHAmphastar

AMLX

Amylyx

AMPH

Amphastar

Grade

Momentum

Value

Sentiment

Setup Bias

Net Neutral

Market Cap

Posture

Defensive

Open Side-by-Side Comparison Compare all

Grade position vs AMPH

AMLX / AMPH

Grade Position

Below peers

AMLX vs. peer average (D vs. C)

30/100

Momentum

AMLX

Value

AMPH

Sentiment

AMLX

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank

Ticker

Company

Grade

Grade score

vs AMLX

AMPH

40/100

Even

ANAB

100/100

-3

ORKA

40/100

Even

PURR

Hyperliquid Strategies Inc Common

N/A

VIR

Vir Biotechnology Inc Common

60/100

-1

AMPH is the first peer returned for this comparison set.